马宝琳胃病中药为啥做不起来(Ma Baolin stomach disease, why cant traditional Chinese medicine do).docVIP

马宝琳胃病中药为啥做不起来(Ma Baolin stomach disease, why cant traditional Chinese medicine do).doc

  1. 1、本文档共11页,可阅读全部内容。
  2. 2、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。
  3. 3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  4. 4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
  5. 5、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
  6. 6、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们
  7. 7、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
  8. 8、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
马宝琳胃病中药为啥做不起来(Ma Baolin stomach disease, why cant traditional Chinese medicine do)

马宝琳胃病中药为啥做不起来(Ma Baolin stomach disease, why cant traditional Chinese medicine do) Why cant Chinese medicine be able to do stomach disease? [case] Case: Xiling Snow R pharmaceutical is an enterprise with 30 years experience in production, belonging to a group of real estate developers. The companys overall sales of less than 100 million yuan. Although have multiple product lines, but many varieties of generic drugs. The marketing mode adopts the investment operation. On 2008, Chinese medicine P in one of the companys listed indications of gastric and duodenal ulcers, hopes to become the core species rise in the drug market, and can put this into Chinese varieties, the best medicine gastric drug products, create Tongxinluo R medicine . There are four main reasons for this speciess absolute confidence: 1.P is the only approved stomach medicine in China in the past 3 years. By a university professor of medicine, in the treatment of ulcer on the basis of experience, after many years of theoretical research and clinical practice, carefully developed products, with 20 years of national patent protection, and has good bactericidal anti-inflammatory, analgesic and anti acid effect of wound repair, the effective rate was above 95%, which determines the P products have strong market competitiveness. 2. business executives think, gastritis, gastric and duodenal ulcer disease incidence rate is high, a large consumer base, and has a relapse, need long-term medication, the capacity of the larger market, foreign blockbusters in Losec, OTC market Sidashu, shows that the market is very large. 3. in the competition, the stomach clinical market mainly western medicine, Chinese medicine is less, in addition to the Yangtze River Pharmaceutical Weisukeli varieties such as billions of dollars, almost no what competitors. For the growth of P products, it is a blue ocean. 4., under the guidance of the policy of combination of traditional Chinese medicine and Western medicine, the traditiona

您可能关注的文档

文档评论(0)

f8r9t5c + 关注
实名认证
文档贡献者

该用户很懒,什么也没介绍

版权声明书
用户编号:8000054077000003

1亿VIP精品文档

相关文档